http://hdl.handle.net/2027.42/78362 2013-05-19T05:49:26Z http://hdl.handle.net/2027.42/75727 Concurrent application of tretinoin (retinoic acid) partially protects against corticosteroid-induced epidermal atrophy McMichael, A. J.; Griffiths, C. E. M.; Talwar, H. S.; Finkel, L. J.; Rafal, E. S.; Hamilton, T. A.; Voorhees, John J. Cutaneous atrophy arising from prolonged use of potent topical corticosteroids has long been a concern. Thus, it would be advantageous to find an agent which protects against atrophy produced by corticosteroids but at the same time does not impair their anti-inflammatory effects. Recent work shows that topical all- trans retinoic acid (tretinoin) prevents skin atrophy in mice treated with topical corticosteroids, but such studies have not been performed in humans. We performed an 8-week clinical, histological and biochemical study to test the ability of tretinoin to enhance efficacy and inhibit atrophogenicity of topical corticosteroids, when used in the treatment of psoriasis. In each of 20 psoriasis patients, one plaque, and its perilesional skin, was treated once daily with betamethasone dipropionate and tretinoin 0 1 , and one plaque, and its perilesional skin, treated with once daily betamethasone dipropionate and tretinoin vehicle. There was no difference in the speed or degree of improvement in plaques treated with either the topical corticosteroid tretinoin combination or with corticosteroid alone. Light microscopy revealed a 19 reduction in epidermal thickness, in corticosteroid-treated perilesional skin, as compared with a slight (1 ) increase in corticosteroid tretinoin-treated perilesional areas (P 0.067). Western blot analysis showed a 55 reduction in procollagen I aminopropeptide in perilesional skin treated with corticosteroid alone, as compared with a 45 reduction in corticosteroid tretinoin-treated perilesional skin. These data indicate that the addition of tretinoin does not impair the efficacy of a topical corticosteroid, in the treatment of psoriasis, and partially ameliorates epidermal atrophy produced by the topical corticosteroid. 1996-07-01T00:00:00Z http://hdl.handle.net/2027.42/75561 Consensus conference on cyclosporin A microemulsion for psoriasis, June 1996 Berth-Jones, J.; Voorhees, John J. 1996-11-01T00:00:00Z http://hdl.handle.net/2027.42/75559 Complete Spontaneous Regression of Pulmonary Metastatic Melanoma Wang, Timothy S.; Lowe, Lori; Smith, John W.; Francis, Isaac R.; Sondak, Vernon K.; Dworzanian, Lynn; Finkelstein, Steven; Slingluff, Craig L.; Johnson, Timothy M. Complete spontaneous regression of melanoma metastatic to the lungs is a rare event. objective . To report a case of biopsy-proven melanoma metastatic to the lung with complete spontaneous regression. methods . Multidisciplinary case report. results . A 35-year-old white female was diagnosed with metastatic melanoma to the lung. A pleural biopsy confirmed the diagnosis. Partial spontaneous regression was noted by a staging computed tomography scan prior to enrollment in an investiga-tional protocol. Complete spontaneous regression occurred over 5 months without any form of conventional or alternative therapy, and the patient remains disease-free 3 years after diagnosis. conclusions . Our case represents the seventh case of complete spontaneous regression of melanoma metastatic to the lung, and the only case with histologic confirmation of both the primary and pulmonary metastatic lesions. The patient was pregnant twice between the time of her initial diagnosis of primary melanoma and pulmonary metastatic disease. 1998-08-01T00:00:00Z http://hdl.handle.net/2027.42/75519 hTERT expression in melanocytic lesions: an immunohistochemical study on paraffin-embedded tissue Fullen, Douglas R.; Zhu, Weijian; Thomas, Dafydd; Su, Lyndon D. Telomerase plays a role in the immortalization of cells and carcinogenesis. Previous studies have yielded conflicting results on whether human telomerase RNA (hTER) expression differs in nevi, atypical nevi and melanomas using polymerase chain reaction-based telomeric repeat amplification protocol or in situ hybridization assays. The aim of this study was to evaluate human telomerase reverse transcriptase (hTERT) staining in melanocytic lesions on paraffin-embedded tissues. Methods:  Paraffin-embedded sections from 12 acquired nevi, seven dysplastic nevi, 11 Spitz nevi, eight primary invasive melanomas, and three metastatic melanomas were studied for staining intensity (0–3+) and percentage of labeled cells with anti-hTERT. Results:  hTERT staining was observed in most cells (>75%), in all but three lesions, and was of greater intensity in the nucleus, especially the nucleolus, compared with the cytoplasm. Spitz nevi tended to have weaker hTERT staining (mean = 1.7) compared with acquired nevi (mean = 2.2), dysplastic nevi (mean = 2.4), primary melanomas (mean = 2.4), or metastatic melanomas (mean = 3). Conclusions:  Although telomerase activity was weaker in Spitz nevi, there was overlap with other nevi and primary invasive melanomas in our small series. Thus, hTERT expression does not appear to be a reliable adjunct to the histological diagnosis of primary melanocytic lesions. Fullen DR, Zhu W, Thomas D, Su LD. hTERT expression in melanocytic lesions: an immunohistochemical study on paraffin-embedded tissue. 2005-11-01T00:00:00Z